Skip to main content

Table 2 Microbiological findings of the study population

From: Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: a prospective cohort study

 

CARDS cases

(n = 16)

IC controls

(n = 12)

Healthy controls

(n = 12)

Bacterial isolates (N)

   

 None

11 (69%)

7 (58%)

12 (100%)

 Klebsiella pneumoniae

1 (6%)

1 (8%)

0 (0%)

 Klebsiella pneumoniae ESBL

1 (6%)

0 (0%)

0 (0%)

 Pseudomonas aeruginosa MDR

0 (0%)

2 (17%)b

0 (0%)

 Enterobacter cloacae

1 (6%)

1 (8%)

0 (0%)

 Staphylococcus aureus

2 (13%)

2 (17%)b

0 (0%)

Fungal isolates (N)

   

 None

11 (69%)

12 (100%)

12 (100%)

 Candida albicans

4a (25%)

0 (0%)

0 (0%)

 Aspergillus fumigatus

2a (13%)

0 (0%)

0 (0%)

Viruses (N)

   

 None

11 (69%)

7 (58%)

12 (100%)

 EBV

1 (6%)

2 (17%)c

0 (0%)

 HSV1

4 (25%)

4 (33%)c

0 (0%)

 CMV

0 (0%)

2 (17%)c

0 (0%)

  1. ESBL extended beta-lactamase, MDR multi drug resistant, EBV Ebstein Barr virus, HSV Herpes Simplex virus, sp species, CMV cytomegalovirus, n number
  2. aIn 1 patient: Aspergillus + Candida
  3. bIn 1 patient: Klebsiella + Staphylococcus
  4. cIn 3 patients, two viruses were detected: HSV1 + CMV, EBV + CMV, EBV + HSV1